BOTANIX PHARMACEUTICALS LTD - Announcements

1.67%

14.8¢

Market Cap $289.2M

Healthcare Biotechnology

Botanix (ASX:BOT) is an ASX-listed dermatology company based in Philadelphia and Phoenix... Botanix (ASX:BOT) is an ASX-listed dermatology company based in Philadelphia and Phoenix (USA), committed to the development of novel treatments for common skin diseases and infections.More

ASX:AFP

Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals (ASX:AFP). With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for stocks in the sector with room to run. Latest:...

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

BOT	Botanix Announces Expansion of Permetrex License	PRICE SENSITIVE	03/02/17	258.58KB	Share
BOT	Quarterly Cashflow Report	PRICE SENSITIVE	30/01/17	746.29KB	Share
BOT	Botanix Announces Positive Human Trial Data	PRICE SENSITIVE	07/12/16	260.31KB	Share
BOT	Botanix Accelerates Clinical Program with First Human Study	PRICE SENSITIVE	11/11/16	262.55KB	Share
BOT	Quarterly Cashflow Report-BOT.AX	PRICE SENSITIVE	31/10/16	552.41KB	Share
BOT	Appendix 4E and Annual Report to Shareholders-BOT.AX	PRICE SENSITIVE	31/08/16	430.82KB	Share
BOT	DEA Scheduling Decision Supports Botanix Approach-BOT.AX	PRICE SENSITIVE	15/08/16	100.41KB	Share
BOT	Botanix Secures Commercial-Scale Synthetic Cannabidiol-BOT.AX	PRICE SENSITIVE	29/07/16	260.95KB	Share
BOT	Reinstatement to Official Quotation - 15 July 2016-BOT.AX	PRICE SENSITIVE	13/07/16	270.11KB	Share
BOT	Suspension-BNE.AX	PRICE SENSITIVE	14/06/16	410.08KB	Share
BOT	Prospectus - Botanix Pharmaceuticals-BNE.AX	PRICE SENSITIVE	13/05/16	1.23MB	Share
BOT	Response to ASX Price Query-BNE.AX	PRICE SENSITIVE	12/05/16	530.45KB	Share
BOT	Appendix 4C - quarterly-BNE.AX	PRICE SENSITIVE	29/04/16	83.95KB	Share
BOT	Acquisition of Botanix Pharmaceuticals Inc	PRICE SENSITIVE	21/03/16	423.12KB	Share
BOT	Trading Halt	PRICE SENSITIVE	18/03/16	240.59KB	Share
BOT	Half Yearly Report and Accounts	PRICE SENSITIVE	19/02/16	166.01KB	Share
BOT	Appendix 4C - quarterly	PRICE SENSITIVE	28/01/16	83.99KB	Share
BOT	Termination of Agreement to acquire Takor	PRICE SENSITIVE	19/11/15	453.81KB	Share
BOT	Trading Halt	PRICE SENSITIVE	17/11/15	404.88KB	Share
BOT	Appendix 4C - quarterly	PRICE SENSITIVE	30/10/15	84.05KB	Share
BOT	Takor Update - Mappt Update & Collaboration Opportunities	PRICE SENSITIVE	05/10/15	526.01KB	Share
BOT	Takor Update	PRICE SENSITIVE	01/09/15	425.39KB	Share
BOT	Appendix 4E and Annual Report to shareholders	PRICE SENSITIVE	28/08/15	1.09MB	Share
BOT	Appendix 4C - quarterly	PRICE SENSITIVE	03/08/15	210.22KB	Share
BOT	BNE to acquire Location Based Geospatial Technology Company	PRICE SENSITIVE	12/05/15	633.04KB	Share
BOT	Trading Halt	PRICE SENSITIVE	08/05/15	169.5KB	Share
BOT	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/15	209.8KB	Share
BOT	Response to Price Query	PRICE SENSITIVE	10/04/15	156.97KB	Share
BOT	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/15	727.38KB	Share
BOT	Appendix 4C - Quarterly Cashflow Report	PRICE SENSITIVE	02/02/15	210.48KB	Share
BOT	Response to ASX Price Query	PRICE SENSITIVE	13/01/15	256.6KB	Share
BOT	BN006 Study Update - Rheumatoid arthritis treatment	PRICE SENSITIVE	09/12/14	246.22KB	Share
BOT	Company Update	PRICE SENSITIVE	19/11/14	296.57KB	Share
BOT	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/14	237.3KB	Share
BOT	Preliminary Final Report & Annual Report to Shareholders	PRICE SENSITIVE	28/08/14	1.21MB	Share
BOT	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/14	237.68KB	Share
BOT	Human Study Commences for Oral Treatment for Osteoporosis	PRICE SENSITIVE	02/07/14	71.53KB	Share
BOT	Continuation of Studies for Rheumatoid Arthritis Treatment	PRICE SENSITIVE	19/06/14	347.46KB	Share
BOT	Approval Received to Commence Human Clinical Study	PRICE SENSITIVE	12/05/14	172.57KB	Share
BOT	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/14	241.03KB	Share
BOT	Human Clinical Study for an Oral Treatment for Osteoporosis	PRICE SENSITIVE	04/04/14	232.77KB	Share
BOT	BN006 Research Collaboration with William Harvey Research	PRICE SENSITIVE	24/03/14	317.04KB	Share
BOT	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/14	123.28KB	Share
BOT	Lexcicon Patent Allowance in Japan	PRICE SENSITIVE	13/02/14	104.84KB	Share
BOT	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/14	109.38KB	Share
BOT	Completion of Capital Raising and Board Changes	PRICE SENSITIVE	28/01/14	134.05KB	Share
BOT	Lexcicon Patent Allowance in Europe	PRICE SENSITIVE	09/01/14	112.65KB	Share
BOT	Bridge Funding Received	PRICE SENSITIVE	18/12/13	105.22KB	Share
BOT	Recapitalisation Agreement Signed With Cornerstone Corporate	PRICE SENSITIVE	28/11/13	147.33KB	Share
BOT	Response to ASX Query	PRICE SENSITIVE	20/11/13	124.14KB	Share
BOT	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/13	51.72KB	Share
BOT	Preliminary Final Report	PRICE SENSITIVE	02/09/13	199.17KB	Share
BOT	Reinstatement to Official Quotation (29.08.13)	PRICE SENSITIVE	28/08/13	78.62KB	Share
ABF +AIE AKW APB ARJ ARR (ASX) 20200701 AZG BEC BGD BHG BIC BOT PFM CMR CNR CPN CPS ECS GEN GIA GNS GNV HST HWE DMC ION IPA KMC MAC MCO MDV MKE MLC MMZ MST MZU NER NGX PLA SAP SDT SNR SOF SRA STI OBM CR3 UCL UXA LGR VIP	Suspension from Official List - Annual Listing Fees	PRICE SENSITIVE	23/08/13	37.97KB	Share
BOT	Funding Update	PRICE SENSITIVE	23/08/13	122.68KB	Share
BOT	Trading Halt	PRICE SENSITIVE	21/08/13	170.23KB	Share
BOT	Funding Update	PRICE SENSITIVE	19/08/13	124.09KB	Share
BOT	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/13	52.09KB	Share
BOT	Axcess II Canada	PRICE SENSITIVE	29/07/13	112.2KB	Share
BOT	Russia Accepts BN006 as a Skolkovo Innovation Priority	PRICE SENSITIVE	17/07/13	129.4KB	Share
BOT	Axcess IV Japan	PRICE SENSITIVE	27/06/13	213.2KB	Share
BOT	Funding Update	PRICE SENSITIVE	26/06/13	125.76KB	Share
BOT	Funding Update	PRICE SENSITIVE	29/05/13	107.04KB	Share
BOT	Australia Grants First Lexcicon Patent	PRICE SENSITIVE	16/05/13	106.33KB	Share
BOT	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/13	106.58KB	Share
BOT	New BN006 Data Stimulates Early Partnering Interest	PRICE SENSITIVE	22/04/13	106.11KB	Share
BOT	Bone Medical Updates Portfolio Strategy	PRICE SENSITIVE	15/04/13	129.51KB	Share
BOT	New Trial Update	PRICE SENSITIVE	08/04/13	122.52KB	Share
BOT	New Mozaic Discovery Technology Publication	PRICE SENSITIVE	28/03/13	151.42KB	Share
BOT	Bone Medical Re-Affirms Oral Calcitonin Strategy	PRICE SENSITIVE	15/03/13	126.21KB	Share
BOT	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/13	1.57MB	Share
BOT	Response to ASX Appendix 4C Query	PRICE SENSITIVE	08/02/13	366.59KB	Share
BOT	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/13	149.92KB	Share
BOT	Proof of Concept Study Initial Findings	PRICE SENSITIVE	21/01/13	131.75KB	Share
BOT	CaPTHymone Clinical Trial Update	PRICE SENSITIVE	18/01/13	124.37KB	Share
BOT	New Oral PTH Clinical Trial Begins Patient Dosing	PRICE SENSITIVE	03/12/12	125.29KB	Share
BOT	Appendix 4C - quarterly	PRICE SENSITIVE	29/10/12	60.4KB	Share
BOT	Bone Medical to Commence New Clinical Trial	PRICE SENSITIVE	02/10/12	125.54KB	Share
BOT	Axcess IV Patent Approved in China	PRICE SENSITIVE	01/10/12	130.47KB	Share
BOT	Preliminary Final Report	PRICE SENSITIVE	31/08/12	537.61KB	Share
BOT	Axcess Oral Peptide Technology in Licensing Deal	PRICE SENSITIVE	06/08/12	137.39KB	Share
BOT	Appendix 4C - quarterly	PRICE SENSITIVE	27/07/12	166.39KB	Share
BOT	Axcess III Patent Granted in US	PRICE SENSITIVE	18/07/12	133.83KB	Share
BOT	Axcess III Patent Received in Japan	PRICE SENSITIVE	05/07/12	130.73KB	Share
BOT	Share Issue	PRICE SENSITIVE	26/06/12	175.78KB	Share
BOT	Share Issue	PRICE SENSITIVE	08/06/12	175.86KB	Share
BOT	Axcess II Patent Received in Japan	PRICE SENSITIVE	06/06/12	130.46KB	Share
BOT	Axcess IV Patent Received in Russia	PRICE SENSITIVE	05/06/12	125.65KB	Share
BOT	Appendix 4C - quarterly	PRICE SENSITIVE	26/04/12	243.36KB	Share
BOT	Partnering Progress Update	PRICE SENSITIVE	26/04/12	133.67KB	Share
BOT	Axcess IV Patent Received in Australia	PRICE SENSITIVE	26/03/12	124.56KB	Share
BOT	New Plans for BN006	PRICE SENSITIVE	20/03/12	127.36KB	Share
BOT	Response to ASX Appendix 4D Query	PRICE SENSITIVE	07/03/12	359.78KB	Share
BOT	Axcess II and III Patent Granted for Korea	PRICE SENSITIVE	06/03/12	131.09KB	Share
BOT	Half Yearly Report and Accounts	PRICE SENSITIVE	29/02/12	556.56KB	Share
BOT	Response to ASX Appendix 4C Query	PRICE SENSITIVE	10/02/12	284.8KB	Share
BOT	Share Issue and Appendix 3B	PRICE SENSITIVE	07/02/12	175.46KB	Share
BOT	Axcess III Patent Granted for Europe	PRICE SENSITIVE	06/02/12	131KB	Share
BOT	Appendix 4C - quarterly	PRICE SENSITIVE	27/01/12	189.74KB	Share
BOT	Response to ASX Query	PRICE SENSITIVE	16/01/12	80.86KB	Share

BOT Botanix Announces Expansion of Permetrex License
03/02/17	PRICE SENSITIVE	258.58KB	Share
BOT Quarterly Cashflow Report
30/01/17	PRICE SENSITIVE	746.29KB	Share
BOT Botanix Announces Positive Human Trial Data
07/12/16	PRICE SENSITIVE	260.31KB	Share
BOT Botanix Accelerates Clinical Program with First Human Study
11/11/16	PRICE SENSITIVE	262.55KB	Share
BOT Quarterly Cashflow Report-BOT.AX
31/10/16	PRICE SENSITIVE	552.41KB	Share
BOT Appendix 4E and Annual Report to Shareholders-BOT.AX
31/08/16	PRICE SENSITIVE	430.82KB	Share
BOT DEA Scheduling Decision Supports Botanix Approach-BOT.AX
15/08/16	PRICE SENSITIVE	100.41KB	Share
BOT Botanix Secures Commercial-Scale Synthetic Cannabidiol-BOT.AX
29/07/16	PRICE SENSITIVE	260.95KB	Share
BOT Reinstatement to Official Quotation - 15 July 2016-BOT.AX
13/07/16	PRICE SENSITIVE	270.11KB	Share
BOT Suspension-BNE.AX
14/06/16	PRICE SENSITIVE	410.08KB	Share
BOT Prospectus - Botanix Pharmaceuticals-BNE.AX
13/05/16	PRICE SENSITIVE	1.23MB	Share
BOT Response to ASX Price Query-BNE.AX
12/05/16	PRICE SENSITIVE	530.45KB	Share
BOT Appendix 4C - quarterly-BNE.AX
29/04/16	PRICE SENSITIVE	83.95KB	Share
BOT Acquisition of Botanix Pharmaceuticals Inc
21/03/16	PRICE SENSITIVE	423.12KB	Share
BOT Trading Halt
18/03/16	PRICE SENSITIVE	240.59KB	Share
BOT Half Yearly Report and Accounts
19/02/16	PRICE SENSITIVE	166.01KB	Share
BOT Appendix 4C - quarterly
28/01/16	PRICE SENSITIVE	83.99KB	Share
BOT Termination of Agreement to acquire Takor
19/11/15	PRICE SENSITIVE	453.81KB	Share
BOT Trading Halt
17/11/15	PRICE SENSITIVE	404.88KB	Share
BOT Appendix 4C - quarterly
30/10/15	PRICE SENSITIVE	84.05KB	Share
BOT Takor Update - Mappt Update & Collaboration Opportunities
05/10/15	PRICE SENSITIVE	526.01KB	Share
BOT Takor Update
01/09/15	PRICE SENSITIVE	425.39KB	Share
BOT Appendix 4E and Annual Report to shareholders
28/08/15	PRICE SENSITIVE	1.09MB	Share
BOT Appendix 4C - quarterly
03/08/15	PRICE SENSITIVE	210.22KB	Share
BOT BNE to acquire Location Based Geospatial Technology Company
12/05/15	PRICE SENSITIVE	633.04KB	Share
BOT Trading Halt
08/05/15	PRICE SENSITIVE	169.5KB	Share
BOT Appendix 4C - quarterly
29/04/15	PRICE SENSITIVE	209.8KB	Share
BOT Response to Price Query
10/04/15	PRICE SENSITIVE	156.97KB	Share
BOT Half Yearly Report and Accounts
25/02/15	PRICE SENSITIVE	727.38KB	Share
BOT Appendix 4C - Quarterly Cashflow Report
02/02/15	PRICE SENSITIVE	210.48KB	Share
BOT Response to ASX Price Query
13/01/15	PRICE SENSITIVE	256.6KB	Share
BOT BN006 Study Update - Rheumatoid arthritis treatment
09/12/14	PRICE SENSITIVE	246.22KB	Share
BOT Company Update
19/11/14	PRICE SENSITIVE	296.57KB	Share
BOT Appendix 4C - quarterly
31/10/14	PRICE SENSITIVE	237.3KB	Share
BOT Preliminary Final Report & Annual Report to Shareholders
28/08/14	PRICE SENSITIVE	1.21MB	Share
BOT Appendix 4C - quarterly
31/07/14	PRICE SENSITIVE	237.68KB	Share
BOT Human Study Commences for Oral Treatment for Osteoporosis
02/07/14	PRICE SENSITIVE	71.53KB	Share
BOT Continuation of Studies for Rheumatoid Arthritis Treatment
19/06/14	PRICE SENSITIVE	347.46KB	Share
BOTApproval Received to Commence Human Clinical Study
12/05/14	PRICE SENSITIVE	172.57KB	Share
BOTAppendix 4C - quarterly
28/04/14	PRICE SENSITIVE	241.03KB	Share
BOTHuman Clinical Study for an Oral Treatment for Osteoporosis
04/04/14	PRICE SENSITIVE	232.77KB	Share
BOTBN006 Research Collaboration with William Harvey Research
24/03/14	PRICE SENSITIVE	317.04KB	Share
BOTHalf Yearly Report and Accounts
27/02/14	PRICE SENSITIVE	123.28KB	Share
BOTLexcicon Patent Allowance in Japan
13/02/14	PRICE SENSITIVE	104.84KB	Share
BOTAppendix 4C - quarterly
31/01/14	PRICE SENSITIVE	109.38KB	Share
BOTCompletion of Capital Raising and Board Changes
28/01/14	PRICE SENSITIVE	134.05KB	Share
BOTLexcicon Patent Allowance in Europe
09/01/14	PRICE SENSITIVE	112.65KB	Share
BOTBridge Funding Received
18/12/13	PRICE SENSITIVE	105.22KB	Share
BOTRecapitalisation Agreement Signed With Cornerstone Corporate
28/11/13	PRICE SENSITIVE	147.33KB	Share
BOTResponse to ASX Query
20/11/13	PRICE SENSITIVE	124.14KB	Share
BOTAppendix 4C - quarterly
31/10/13	PRICE SENSITIVE	51.72KB	Share
BOTPreliminary Final Report
02/09/13	PRICE SENSITIVE	199.17KB	Share
BOTReinstatement to Official Quotation (29.08.13)
28/08/13	PRICE SENSITIVE	78.62KB	Share
ABF +AIE AKW APB ARJ ARR (ASX) 20200701 AZG BEC BGD BHG BIC BOT PFM CMR CNR CPN CPS ECS GEN GIA GNS GNV HST HWE DMC ION IPA KMC MAC MCO MDV MKE MLC MMZ MST MZU NER NGX PLA SAP SDT SNR SOF SRA STI OBM CR3 UCL UXA LGR VIPSuspension from Official List - Annual Listing Fees
23/08/13	PRICE SENSITIVE	37.97KB	Share
BOTFunding Update
23/08/13	PRICE SENSITIVE	122.68KB	Share
BOTTrading Halt
21/08/13	PRICE SENSITIVE	170.23KB	Share
BOTFunding Update
19/08/13	PRICE SENSITIVE	124.09KB	Share
BOTAppendix 4C - quarterly
31/07/13	PRICE SENSITIVE	52.09KB	Share
BOTAxcess II Canada
29/07/13	PRICE SENSITIVE	112.2KB	Share
BOTRussia Accepts BN006 as a Skolkovo Innovation Priority
17/07/13	PRICE SENSITIVE	129.4KB	Share
BOTAxcess IV Japan
27/06/13	PRICE SENSITIVE	213.2KB	Share
BOTFunding Update
26/06/13	PRICE SENSITIVE	125.76KB	Share
BOTFunding Update
29/05/13	PRICE SENSITIVE	107.04KB	Share
BOTAustralia Grants First Lexcicon Patent
16/05/13	PRICE SENSITIVE	106.33KB	Share
BOTAppendix 4C - quarterly
30/04/13	PRICE SENSITIVE	106.58KB	Share
BOTNew BN006 Data Stimulates Early Partnering Interest
22/04/13	PRICE SENSITIVE	106.11KB	Share
BOTBone Medical Updates Portfolio Strategy
15/04/13	PRICE SENSITIVE	129.51KB	Share
BOTNew Trial Update
08/04/13	PRICE SENSITIVE	122.52KB	Share
BOTNew Mozaic Discovery Technology Publication
28/03/13	PRICE SENSITIVE	151.42KB	Share
BOTBone Medical Re-Affirms Oral Calcitonin Strategy
15/03/13	PRICE SENSITIVE	126.21KB	Share
BOTHalf Yearly Report and Accounts
28/02/13	PRICE SENSITIVE	1.57MB	Share
BOTResponse to ASX Appendix 4C Query
08/02/13	PRICE SENSITIVE	366.59KB	Share
BOTAppendix 4C - quarterly
31/01/13	PRICE SENSITIVE	149.92KB	Share
BOTProof of Concept Study Initial Findings
21/01/13	PRICE SENSITIVE	131.75KB	Share
BOTCaPTHymone Clinical Trial Update
18/01/13	PRICE SENSITIVE	124.37KB	Share
BOTNew Oral PTH Clinical Trial Begins Patient Dosing
03/12/12	PRICE SENSITIVE	125.29KB	Share
BOTAppendix 4C - quarterly
29/10/12	PRICE SENSITIVE	60.4KB	Share
BOTBone Medical to Commence New Clinical Trial
02/10/12	PRICE SENSITIVE	125.54KB	Share
BOTAxcess IV Patent Approved in China
01/10/12	PRICE SENSITIVE	130.47KB	Share
BOTPreliminary Final Report
31/08/12	PRICE SENSITIVE	537.61KB	Share
BOTAxcess Oral Peptide Technology in Licensing Deal
06/08/12	PRICE SENSITIVE	137.39KB	Share
BOTAppendix 4C - quarterly
27/07/12	PRICE SENSITIVE	166.39KB	Share
BOTAxcess III Patent Granted in US
18/07/12	PRICE SENSITIVE	133.83KB	Share
BOTAxcess III Patent Received in Japan
05/07/12	PRICE SENSITIVE	130.73KB	Share
BOTShare Issue
26/06/12	PRICE SENSITIVE	175.78KB	Share
BOTShare Issue
08/06/12	PRICE SENSITIVE	175.86KB	Share
BOTAxcess II Patent Received in Japan
06/06/12	PRICE SENSITIVE	130.46KB	Share
BOTAxcess IV Patent Received in Russia
05/06/12	PRICE SENSITIVE	125.65KB	Share
BOTAppendix 4C - quarterly
26/04/12	PRICE SENSITIVE	243.36KB	Share
BOTPartnering Progress Update
26/04/12	PRICE SENSITIVE	133.67KB	Share
BOTAxcess IV Patent Received in Australia
26/03/12	PRICE SENSITIVE	124.56KB	Share
BOTNew Plans for BN006
20/03/12	PRICE SENSITIVE	127.36KB	Share
BOTResponse to ASX Appendix 4D Query
07/03/12	PRICE SENSITIVE	359.78KB	Share
BOTAxcess II and III Patent Granted for Korea
06/03/12	PRICE SENSITIVE	131.09KB	Share
BOTHalf Yearly Report and Accounts
29/02/12	PRICE SENSITIVE	556.56KB	Share
BOTResponse to ASX Appendix 4C Query
10/02/12	PRICE SENSITIVE	284.8KB	Share
BOTShare Issue and Appendix 3B
07/02/12	PRICE SENSITIVE	175.46KB	Share
BOTAxcess III Patent Granted for Europe
06/02/12	PRICE SENSITIVE	131KB	Share
BOTAppendix 4C - quarterly
27/01/12	PRICE SENSITIVE	189.74KB	Share
BOTResponse to ASX Query
16/01/12	PRICE SENSITIVE	80.86KB	Share

REFRESH

First 2 3

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 14.8¢		Change -0.003(1.67%)		Mkt cap ! $289.2M

Open	High	Low	Value	Volume
15.0¢	15.3¢	14.0¢	$1.066M	7.294M

Buyers (Bids)

No.	Vol.	Price($)
24	2061834	14.5¢

Sellers (Offers)

Price($)	Vol.	No.
15.0¢	1234302	15

View Market Depth

No.	Vol.	Price($)
15	776200	0.145
124	4853764	0.140
59	1740068	0.135
73	10384856	0.130
31	824654	0.125

Price($)	Vol.	No.
0.150	1244302	16
0.155	1425130	22
0.160	2522601	28
0.165	375376	15
0.170	1322734	29

Last trade - 10.53am 01/08/2025 (20 minute delay)


Last 14.8¢		Change -0.003 ( 2.51 %)
Open	High	Low	Volume
15.0¢	15.0¢	14.3¢	4547171
Last updated 11.12am 01/08/2025 ?

BOT (ASX) Chart

BOTANIX PHARMACEUTICALS LTD - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Codeifai looks to ride AI wave as Quantum Computing becomes a necessity

Prospect Resources: Replicating the success of Arcadia with ~1b tonne copper ore target

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

Top Stories